April 03, 2012
ZyCal Bioceuticals, Inc., a nutritional supplement manufacturing company specializing in bone and joint health, celebrates osteoporosis awareness month by giving away a free bottle of calcium (Tricalcidin-3®) with a purchase of any Ostinol™ branded product. The free calcium is available with the coupon code TRI312.
Ostinol™ is an all natural product, including bone and cartilage stimulating proteins to address the underlying problems of bone and joint health. Ostinol™ is effective due to the natural immunoprotective effect these proteins have in the human body. The proteins in Ostinol™ naturally protect against the pathways which cause inflammation and the ensuing pain that follows. The end result is people report feeling better in days, while the cartilage-growing pathway is being stimulated.
“In as little as one year, people have reported bone growth and even faster results, within days to weeks, are reported from people with joint pain,” says James Scaffidi, President and CEO of Zycal Bioceuticals, Inc. Specifically, Ostinol™ stimulates cells which grow bone and cartilage, aids in arthritis, osteoporosis, fibromyalgia and osteopenia. “The Ostinol™ product is supported by 40 years of research and 20 years of clinical use and has been the standard of care for years, used by thousands of healthcare professionals and patients,” said Scaffidi.
The coupon can been redeemed by ordering Ostinol™ online today or by calling customer service at 1-888-779-9225 ext. About ZyCal Bioceuticals, Inc.
ZyCal Bioceuticals, Inc...Ostinol™ is the first and only natural product containing powerful proteins used medically for 20 years to turn on stem cells for bone and cartilage growth. The company is headquartered in Toms River, New Jersey. Since its founding in 2006, ZyCal Bioceuticals has developed and launched the first biologically active class of protein-based products containing BMPs (Bone Morphogenetic Proteins) and growth factors as a nutritional supplement.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/4/prweb9363613.htm